Literature DB >> 30092578

lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.

Chuan He1, Zhigang Liu1, Li Jin2, Fang Zhang2, Xinhao Peng2, Yaqin Xiao2, Xi Wang2, Qian Lyu3, XiaoJun Cai4.   

Abstract

BACKGROUND/AIMS: MicroRNA-142-3p (miR-142-3p) is dysregulated in many malignancies and may function as a tumor suppressor or oncogene in tumorigenesis and tumor development. However, few studies have investigated the clinical significance and biological function of miR-142-3p in hepatocellular carcinoma (HCC).
METHODS: The expression levels of taurine upregulated gene 1 (TUG1), miR-142-3p, and zinc finger E-box-binding homeobox 1 (ZEB1) were evaluated in HCC tissues and cell lines by quantitative real-time PCR. MTT and colony formation assays were used to detect cell proliferation ability, transwell assays were used to assess cell migration and invasion, and luciferase reporter assays were used to examine the interaction between the long noncoding RNA TUG1 and miR-142-3p. Tumor formation was evaluated through in vivo experiments.
RESULTS: miR-142-3p was significantly downregulated in HCC tissues, but TUG1 was upregulated in HCC tissues. Knockdown of TUG1 and upregulation of miR-142-3p inhibited cell proliferation, cell migration, cell invasion, and the epithelial-mesenchymal transition (EMT). miR-142-3p was found to be a prognostic factor of HCC, and the mechanism by which TUG1 upregulated ZEB1 was via direct binding to miR-142-3p. In vivo assays showed that TUG1 knockdown suppressed cell proliferation and the EMT in nude mice.
CONCLUSION: The results of this study suggest that the TUG1/miR-142-3p/ ZEB1 axis contributes to the formation of malignant behaviors in HCC.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  EMT; Hepatocellular carcinoma; Lncrna TUG1; MiR-142-3p; ZEB1

Mesh:

Substances:

Year:  2018        PMID: 30092578     DOI: 10.1159/000492517

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  22 in total

Review 1.  Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review).

Authors:  Stella Baliou; Anthony M Kyriakopoulos; Demetrios A Spandidos; Vassilios Zoumpourlis
Journal:  Int J Oncol       Date:  2020-07-14       Impact factor: 5.650

2.  Long non-coding RNA LINC00473 acts as a microRNA-29a-3p sponge to promote hepatocellular carcinoma development by activating Robo1-dependent PI3K/AKT/mTOR signaling pathway.

Authors:  Qiqin Song; Hongyue Zhang; Jinan He; Hongyan Kong; Ran Tao; Yu Huang; Haijing Yu; Zhongwei Zhang; Zhiyong Huang; Lai Wei; Chenghai Liu; Likui Wang; Qin Ning; Jiaquan Huang
Journal:  Ther Adv Med Oncol       Date:  2020-08-27       Impact factor: 8.168

3.  LncRNA TUG1 regulates autophagy-mediated endothelial-mesenchymal transition of liver sinusoidal endothelial cells by sponging miR-142-3p.

Authors:  Rui Zhang; Xiao-Quan Huang; Ying-Yi Jiang; Na Li; Jian Wang; Shi-Yao Chen
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

4.  miR‑300 regulates tumor proliferation and metastasis by targeting lymphoid enhancer‑binding factor 1 in hepatocellular carcinoma.

Authors:  Yufo Chen; Yuanyuan Guo; Yawei Li; Jingwen Yang; Jing Liu; Qiong Wu; Rui Wang
Journal:  Int J Oncol       Date:  2019-02-13       Impact factor: 5.650

5.  MALAT1 functions as a competing endogenous RNA to regulate SMAD5 expression by acting as a sponge for miR-142-3p in hepatocellular carcinoma.

Authors:  Qiangfeng Yu; Leyang Xiang; Zhanjun Chen; Xincheng Liu; Huohui Ou; Jianyin Zhou; Dinghua Yang
Journal:  Cell Biosci       Date:  2019-05-10       Impact factor: 7.133

6.  Long noncoding RNA TUG1 promotes proliferation and inhibits apoptosis in multiple myeloma by inhibiting miR-29b-3p.

Authors:  Dahai Liu; Jianfeng Wang; Meihan Liu
Journal:  Biosci Rep       Date:  2019-03-22       Impact factor: 3.840

Review 7.  Molecular mechanisms of TUG1 in the proliferation, apoptosis, migration and invasion of cancer cells.

Authors:  Hui Zhou; Lina Sun; Fusheng Wan
Journal:  Oncol Lett       Date:  2019-09-10       Impact factor: 2.967

8.  Targeting Long Non-Coding RNAs in Hepatocellular Carcinoma: Progress and Prospects.

Authors:  Xinrong Lin; Xiaosong Xiang; Bing Feng; Hao Zhou; Ting Wang; Xiaoyuan Chu; Rui Wang
Journal:  Front Oncol       Date:  2021-06-25       Impact factor: 6.244

9.  miR‑1299/NOTCH3/TUG1 feedback loop contributes to the malignant proliferation of ovarian cancer.

Authors:  Yuqing Pei; Kexin Li; Xiaoying Lou; Yue Wu; Xin Dong; Wenpeng Wang; Ning Li; Donghong Zhang; Wei Cui
Journal:  Oncol Rep       Date:  2020-05-25       Impact factor: 3.906

Review 10.  Homeobox Genes and Hepatocellular Carcinoma.

Authors:  Kwei-Yan Liu; Li-Ting Wang; Shih-Hsien Hsu; Shen-Nien Wang
Journal:  Cancers (Basel)       Date:  2019-05-03       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.